GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guangdong Taiantang Pharmaceutical Co Ltd (SZSE:002433) » Definitions » Gross-Profit-to-Asset %

Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Gross-Profit-to-Asset % : 1.33% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Guangdong Taiantang Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Guangdong Taiantang Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Mar. 2024 was ¥44.1 Mil. Guangdong Taiantang Pharmaceutical Co's average Total Assets over the quarter that ended in Mar. 2024 was ¥3,313.9 Mil. Therefore, Guangdong Taiantang Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 1.33%.


Guangdong Taiantang Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Guangdong Taiantang Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong Taiantang Pharmaceutical Co Gross-Profit-to-Asset % Chart

Guangdong Taiantang Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.21 10.42 6.34 4.12 1.52

Guangdong Taiantang Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.57 3.15 1.56 -2.44 1.33

Competitive Comparison of Guangdong Taiantang Pharmaceutical Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Guangdong Taiantang Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Taiantang Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guangdong Taiantang Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Guangdong Taiantang Pharmaceutical Co's Gross-Profit-to-Asset % falls into.



Guangdong Taiantang Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Guangdong Taiantang Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=69.165/( (5776.437+3343.704)/ 2 )
=69.165/4560.0705
=1.52 %

Guangdong Taiantang Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=44.12/( (3343.704+3284.118)/ 2 )
=44.12/3313.911
=1.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Guangdong Taiantang Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Guangdong Taiantang Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Business Description

Traded in Other Exchanges
N/A
Address
No. 888 North Sichuan Road, 25th Floor, Haitai International Building, Hongkou District, Shanghai, CHN, 200080
Guangdong Taiantang Pharmaceutical Co Ltd is a China-based pharmaceutical company engaged in the research, manufacture and sale of high-effect skin-drugs.
Executives
Ke Shao Fang Directors, executives
Hu Qing Guang Director
Song Xiu Qing Director
Ke Shu Quan Director

Guangdong Taiantang Pharmaceutical Co (SZSE:002433) Headlines

No Headlines